147 related articles for article (PubMed ID: 16946566)
1. Low-dose growth hormone treatment (0.175 mg/kg/week) for short stature in patients with Turner Syndrome: data from KIGS Japan.
Ito Y; Fujieda K; Tanaka T; Takano K; Chihara K; Seino Y; Irie M;
Endocr J; 2006 Oct; 53(5):699-703. PubMed ID: 16946566
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
[TBL] [Abstract][Full Text] [Related]
3. The use of somatropin (recombinant growth hormone) in children of short stature.
Mehta A; Hindmarsh PC
Paediatr Drugs; 2002; 4(1):37-47. PubMed ID: 11817985
[TBL] [Abstract][Full Text] [Related]
4. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
[TBL] [Abstract][Full Text] [Related]
5. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
[TBL] [Abstract][Full Text] [Related]
6. Height gain in Ullrich-Turner syndrome after early and late growth hormone treatment start: results from a large retrospective German study and potential basis for an individualized treatment approach.
Bettendorf M; Inta IM; Doerr HG; Hauffa BP; Mehls O; Ranke MB
Horm Res Paediatr; 2013; 80(5):356-62. PubMed ID: 24217296
[TBL] [Abstract][Full Text] [Related]
7. Reference curve for the first-year growth response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency: validation of the KIGS first-year growth response curve using the Belgian Register for the Study of Growth and Puberty Problems.
Straetemans S; Roelants M; Thomas M; Rooman R; De Schepper J
Horm Res Paediatr; 2014; 81(5):343-9. PubMed ID: 24686034
[TBL] [Abstract][Full Text] [Related]
8. Growth Hormone Treatment at Nippon Medical School Chiba Hokusoh Hospital.
Kuramochi E; Mae K; Ohtomo Y; Kamada R; Sugano-Tajima H; Asano T
J Nippon Med Sch; 2021 Mar; 88(1):39-44. PubMed ID: 32475901
[TBL] [Abstract][Full Text] [Related]
9. International Comparison of Adult Height in Children with Growth Hormone Deficiency and Limitations of Growth Hormone Treatment in Japan.
Tanaka T
Pediatr Endocrinol Rev; 2017 Mar; 14 Suppl 1(Suppl 1):216-221. PubMed ID: 28516749
[TBL] [Abstract][Full Text] [Related]
10. A decade of growth hormone treatment in girls with Turner syndrome in the UK. UK KIGS Executive Group.
Betts PR; Butler GE; Donaldson MD; Dunger DB; Johnston DI; Kelnar CJ; Kirk J; Price DA; Wilton P
Arch Dis Child; 1999 Mar; 80(3):221-5. PubMed ID: 10325700
[TBL] [Abstract][Full Text] [Related]
11. [GH-secretion capacity in Turner syndrome and its relations to clinical characteristics and effect of GH treatment--a comparison with pituitary dwarfism. The Committee for hGH treatment in Turner syndrome].
Tanaka T; Hibi I; Shizume K
Nihon Naibunpi Gakkai Zasshi; 1991 May; 67(5):597-610. PubMed ID: 1868920
[TBL] [Abstract][Full Text] [Related]
12. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials of GH treatment in patients with Turner's syndrome in Japan--a consideration of final height. The Committee for the Treatment of Turner's Syndrome.
Takano K; Ogawa M; Tanaka T; Tachibana K; Fujita K; Hizuka N
Eur J Endocrinol; 1997 Aug; 137(2):138-45. PubMed ID: 9272101
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of growth hormone treatment on height in Turner syndrome: results of a 6-year multicentre study in Japan. Committee for the Treatment of Turner Syndrome.
Takano K; Shizume K; Hibi I; Ogawa M; Okada Y; Suwa S; Tanaka T; Hizuka N
Horm Res; 1995; 43(4):141-3. PubMed ID: 7750916
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
[TBL] [Abstract][Full Text] [Related]
16. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
Darendeliler F; Berberoğlu M; Ocal G; Adiyaman P; Bundak R; Günöz H; Baş F; Darcan S; Gökşen D; Arslanoğlu I; Yildiz M; Ercan O; Ercan G; Ozerkan E; Can S; Böber E; Adal E; Sarikaya S; Dallar Y; Siklar Z; Bircan I; Bideci A; Yüksel B; Büyükgebiz A
J Pediatr Endocrinol Metab; 2005 Oct; 18(10):949-54. PubMed ID: 16355808
[TBL] [Abstract][Full Text] [Related]
17. Comparison of growth response and adverse reaction according to growth hormone dosing strategy for children with short stature: LG Growth Study.
Song K; Jung MK; Oh JS; Kim SJ; Choi HS; Lee M; Suh J; Kwon A; Chae HW; Kim HS
Growth Horm IGF Res; 2023; 69-70():101531. PubMed ID: 36906505
[TBL] [Abstract][Full Text] [Related]
18. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001.
Ranke MB; Partsch CJ; Lindberg A; Dorr HG; Bettendorf M; Hauffa BP; Schwarz HP; Mehls O; Sander S; Stahnke N; Steinkamp H; Said E; Sippell W
Eur J Endocrinol; 2002 Nov; 147(5):625-33. PubMed ID: 12444894
[TBL] [Abstract][Full Text] [Related]
19. Final height in Turner syndrome patients treated with growth hormone.
Pasquino AM; Passeri F; Municchi G; Segni M; Pucarelli I; Larizza D; Bossi G; Severi F; Galasso C
Horm Res; 1996; 46(6):269-72. PubMed ID: 8982737
[TBL] [Abstract][Full Text] [Related]
20. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
